Konakion Prima Infanzia

Phytomenadione, the active ingredient in Konakion Prima Infanzia, is a vitamin K presented as a sterile solution for intramuscular, intravenous, or oral use. It is employed to prevent vitamin K deficiency bleeding in newborns, treat established vitamin K deficiency, and reverse the effects of anticoagulant therapy. GNH USA supplies Konakion Prima Infanzia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Konakion Prima Infanzia is a vitamin K hemostatic agent used in conditions affecting the clotting cascade. - Prevention of vitamin K deficiency bleeding in newborns: reduces the risk of early and late hemorrhagic disease of the newborn. - Treatment of vitamin K deficiency: restores normal activity of clotting factors II, VII, IX and X. - Reversal of anticoagulant therapy: re‑establishes clotting factor function after vitamin K antagonist use.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Redness at injection site: localized erythema that resolves spontaneously. - Mild fever: transient low‑grade temperature elevation. - Transient headache: brief episodes of mild head discomfort.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe allergic reaction: including angioedema or urticaria. - Hemolysis: rare destruction of red blood cells. - Thrombosis: very rare formation of abnormal blood clots.

Konakion Prima Infanzia should be used with careful clinical assessment. - Assess vitamin K status before administration: ensure deficiency is confirmed. - Use with caution in newborns with cholestasis: impaired absorption may affect efficacy. - Monitor for signs of allergic reaction: observe for rash, swelling, or breathing difficulty. - Avoid in patients with known hypersensitivity to phytomenadione: contraindicated. - Do not co‑administer high‑dose vitamin E without monitoring: may alter coagulation balance. - Store at ambient temperature: keep in original container, protect from moisture and light.

Phytomenadione may interact with several medications. Major Interactions (Avoid): - Warfarin: may reduce anticoagulant effect, leading to sub‑therapeutic anticoagulation. - Broad‑spectrum antibiotics (e.g., cefoperazone): may interfere with endogenous vitamin K synthesis, altering response. Moderate Interactions (Monitor Closely): - Heparin: additive anticoagulant effect may increase bleeding risk. - Vitamin E supplements: may potentiate anticoagulant activity, requiring monitoring. - Other vitamin K‑containing products: concurrent use may cause excess vitamin K levels.